Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review

Date: March 22, 2016
Pages: 35
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M2D1B9F7128EN
Leaflet:

Download PDF Leaflet

Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review
Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Mabion SA (Mabion) is a biotechnology company that focuses on developing pharmaceutical products based on humanized monoclonal antibodies. It develops its therapeutic antibodies for the treatment of various cancers and autoimmune diseases. The company also offers contract research and development services related to recombinant proteins, including human insulin, human insulin analogues, and animal insulins. Mabion was formed as a joint venture among four companies namely, Celon Pharma Lomianki, Polfarmex, IBSS Biomed and Genexo. The company operates its research and development facility in located in Lodz. The company also conducts its R&D through its subsidiaries, BioCentrum and Biotech Consulting. Mabion is headquartered at Kutno, Lodz province, Poland.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Mabion SA - Key Facts
Mabion SA - Key Employees
Mabion SA - Major Products and Services
Mabion SA - Pharmaceutical Pipeline Products Data
Mabion SA, Pipeline Products by Therapy Area
Mabion SA, Pipeline Products by Development Phase
Mabion SA - History
Mabion SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Mabion SA - Business Description
Mabion SA - Corporate Strategy
Mabion SA - SWOT Analysis
SWOT Analysis - Overview
Mabion SA - Strengths
Strength - Comprehensive Range of Services
Strength - Strong Foundation
Strength - Lead Product – MabionCD20
Mabion SA - Weaknesses
Weakness - History of Losses
Weakness - Cost Control
Mabion SA - Opportunities
Opportunity - Contracts and Agreements
Opportunity - Pipeline Products
Opportunity - Rapidly Growing Biosimilars Market
Mabion SA - Threats
Threat - Intense Competition
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Mabion SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Mabion SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Mabion SA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Mabion SA, Recent Deals Summary

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Mabion SA, Key Facts
Mabion SA, Key Employees
Mabion SA, Major Products and Services
Mabion SA, Number of Pipeline Products by Therapy Area
Mabion SA, Number of Pipeline Products by Development Stage
Mabion SA, Pipeline Products By Therapy Area and Development Phase
Mabion SA, History
Mabion SA, Other Locations
Mabion SA, Key Competitors
Mabion SA, Ratios based on current share price
Mabion SA, Annual Ratios
Mabion SA, Interim Ratios
Mabion SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Mabion SA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Mabion SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Mabion SA, Pipeline Products by Therapy Area
Mabion SA, Pipeline Products by Development Phase
Mabion SA, Performance Chart (2010 - 2014)
Mabion SA, Ratio Charts
Mabion SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Mabion SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: